Abstract:Objective. Modified C-reactive protein (mCRP) is known to be involved in the upregulation and amplification of the local inflammatory response. This study investigated the circulating and local levels of mCRP and their relevance to clinicopathological features in patients with lupus nephritis.Methods. Ninety-five patients with renal biopsy-proven lupus nephritis and 30 normal controls were enrolled in this study. Plasma and urinary mCRP were screened by enzyme-linked immunosorbent assay (ELISA). The renal deposition of mCRP was detected by immunohistochemistry and immunofluorescence staining. A human proximal tubular epithelial cell line (HK2 cells) was incubated with purified IgG from lupus nephritis, and the production of CRP by HK2 cells was further evaluated.Results. Plasma and urinary levels of mCRP increased significantly in patients with lupus nephritis compared with normal controls (P=0.013, P<0.001, respectively). The urinary mCRP levels were associated with interstitial inflammatory cell infiltration (r = 0.514, P<0.001) and interstitial fibrosis (r = 0.270, P=0.008). The ROC-AUC of the urinary mCRP levels for diagnosing tubulointerstitial lesions was 0.766. The urinary mCRP levels were closely associated with poor outcomes (HR: 1.204, 95% CI: 1.029-1.409, P=0.020). However, no correlations were found of the plasma mCRP levels with clinicopathological data or the prognosis of lupus nephritis. CRP was mostly deposited in the renal tubules in patients with lupus nephritis, and the expression of CRP was significantly correlated with tubulointerstitial lesion indices. Immunofluorescence staining showed that mCRP could colocalize with IgG in tubules. Lupus nephritis-derived IgG could induce CRP production by HK2 cells.Conclusion. Urinary mCRP levels were significantly increased, and urinary mCRP might be a biomarker for tubulointerstitial lesions in patients with lupus nephritis. Renal CRP could be produced by tubular epithelial cells after stimulation by lupus nephritis-derived IgG, and the local presence of mCRP might play a critical role in the development of tubulointerstitial lesions.

The anti-mCRP199-206 antibodies aggravate tubulointerstitial lesions in lupus nephritis

Urinary Modified C-Reactive Protein is Closely Associated with Tubulointerstitial Lesions in Lupus Nephritis.

The Role of Anti-mCRP Autoantibodies in Lupus Nephritis.

Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.

TLR4+CXCR4+ Plasma Cells Drive Nephritis Development in Systemic Lupus Erythematosus

Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis

Monocyte Chemoattractant Protein-1 Expression in Renal Tissue is Associated with Monocyte Recruitment and Tubulo-Interstitial Lesions in Patients with Lupus Nephritis.

Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice

Autoantibodies Against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis

Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.

Lipocalin-2 Exacerbates Lupus Nephritis by Promoting Th1 Cell Differentiation

Modified C-reactive Protein Might Be a Target Autoantigen of TINU Syndrome.

Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses.

Expression and clinical significance of TLR9 and Mcp-1 in renal tissue of patients with lupus

C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice

Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study

Tubular Basement Membrane Immune Complex Deposition is Associated with Activity and Progression of Lupus Nephritis: a Large Multicenter Chinese Study

Serum Level of Anti-Monomer C-reactive Protein Antibody in Systemic Lupus Erythematosus

Anti-mesangial Cell Autoantibodies and Their Target Antigens in Lupus Nephritis

Podocyte Activation of Nlrp3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis

Anti-C1q Autoantibodies from Active Lupus Nephritis Patients Could Inhibit the Clearance of Apoptotic Cells and Complement Classical Pathway Activation Mediated by C1q in Vitro.